Adage Capital Partners Gp, L.L.C. Solid Biosciences Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $1.39 Million - $6.35 Million	-492,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $2.13 Million - $5.73 Million	492,000 New	492,000 $5.09 Million
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $2.98 Million - $6.49 Million	-140,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $4 Million - $5.69 Million	-110,000 Reduced 44.0%	140,000 $6.61 Million
Q2 2018 Aug 14, 2018	SELL	$7.33 - $43.15 $2.2 Million - $12.9 Million	-300,000 Reduced 54.55%	250,000 $8.91 Million
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $3.95 Million - $18.2 Million	550,000 New	550,000 $4.13 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $34.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.